Speech-Language Pathologists in Fargo, ND Accepting Medicare

240 Speech-Language Pathologists found. Showing 61 - 80

Lindsay Wickham, MS/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-6862

James W Dulka, M.S., CF-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1411 32nd St S, Fargo, ND 58103 Phone: 701-532-1507

Whitney J Voss, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1702 University Dr S, Fargo, ND 58103 Phone: 701-364-8000

Katie B Bergh, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3003 32nd Ave S, Fargo, ND 58103 Phone: 701-232-2340

Erin Jore Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3001 11th St S, Fargo, ND 58103 Phone: 701-356-0062    Fax: 701-356-5412

Mrs. Brenda Joan Patzner, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3003 32nd Ave S, Suite 9, Fargo, ND 58103 Phone: 701-232-2340    Fax: 701-232-2330

Amanda Lachance, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1720 University Dr S, Fargo, ND 58103 Phone: 701-417-4437    Fax: 701-417-4069

Mrs. Kimberly Joan Smith, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-5799

Mckenzie Lee Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1717 S University, Feeding Disorders 3rd Floor, Fargo, ND 58103 Phone: 701-417-5294

Nanette S Kennelly, MS CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1220 Main Ave, Suite 100, Fargo, ND 58103 Phone: 701-364-5433    Fax: 701-364-2256

Mr. Jill Suzanne Suppes, MS-CCC/SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 3001 University Dr S, Fargo, ND 58103 Phone: 701-356-0062

Alyce A. Wiemken, MS, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2810 Parkview Cir S, Fargo, ND 58103 Phone: 701-298-9767

Meghan Partridge, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6681 56th Ave S, Fargo, ND 58104 Phone: 701-232-1215

Melanie J Mcnutt, MS-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8000    Fax: 701-364-8078

Rachel Elizabeth Stoltman Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2846 Brandt Dr S, Fargo, ND 58104 Phone: 701-232-2340    Fax: 701-232-2330

Cassandra Andress Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1720 University Dr S, Fargo, ND 58103 Phone: 701-417-4012

Kelsey Jolene Kowalski, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8000

Ann Marie Schmit Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3003 32nd Ave S, Suite 9, Fargo, ND 58103 Phone: 701-232-2340    Fax: 701-232-2330

Stephanie Peterson, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1720 University Dr S, Fargo, ND 58103 Phone: 701-417-4085

Tessa Samson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3060 Frontier Way S, Fargo, ND 58104 Phone: 701-232-2340

News Archive

At last the culprit in Autism is revealed

An international team of scientists have discovered two new genetic links that may predispose children to develop autism.

B.1.1.7 variant 45% more infectious than wild-type SARS-CoV-2, but can be effectively contained by BNT162b2 vaccine

The SARS-CoV-2 B.1.1.7 variant, also called the UK variant, was identified in London as well as in Southeast and East of England in December 2020. Since its emergence, the UK variant has undergone several mutations that have been said to have altered its infectivity and transmissibility in the community. The B.1.1.7 variant is defined by 17 mutations, several of which are located in the SARS-CoV-2 spike protein that mediates viral attachment and entry into human cells.

Pfizer, Medivation announce results of two dimebon Phase 3 trials in AD patients

Pfizer Inc. and Medivation, Inc. today announced results from two Phase 3 trials of the investigational drug dimebon (latrepirdine) in patients with Alzheimer's disease (AD). In the CONNECTION trial, dimebon did not meet its co-primary or secondary efficacy endpoints compared to placebo. Co-primary endpoints were measures of cognition and global function.

Hormones & Cancer: A new journal from The Endocrine Society

Today, The Endocrine Society unveiled its newest journal, Hormones & Cancer. This bi-monthly journal will include research articles covering all aspects of hormone action on cancer causation, progression, dependence, prevention, resistance and treatment.

Read more Medical News

› Verified 2 days ago

• 1
• 2
• 3
• 4(current)
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• »